Intended Audience: Physicians (PCPs, Pediatricians, Family Medicine, and Internal Medicine), Advanced Practitioners (NPs and PAs), Nurses, and Pharmacists
Listen in as Dr John Russell and a panel of renowned experts tackle pressing questions in atopic dermatitis (AD) care, offering their insightful perspectives to help you improve outcomes for your patients with AD.
Learn about:
- The latest clinical evidence and how it's shaping AD assessment, treatment, and management
- Pioneers in the field who are building bridges between specialty and primary care teams to optimize shared management of AD
Physicians completing this activity will earn AMA PRA Category 1 Credit™ classified as enduring material.
Speaker
Clinical Professor, Family & Community Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Chair, Department of Family Medicine
Director, Family Medicine Residency Program
Abington Hospital-Jefferson Health
Philadelphia, PA
Speaker
Associate Dean and Director of Clinical Research
Southern California Clinical and Translational Science Institute (CTSI)
Vice Chair of Clinical Research and Professor of Dermatology
Director of Clinical Trials and Outcomes Research
Director of Psoriasis Program, Department of Dermatology
University of Southern California Keck School of Medicine
Los Angeles, CA
Planner
National Clinical Nursing Director
Multiple Sclerosis Center of Excellence East
Washington DC VA Medical Center
Washington, DC
Planner
Adult Nurse Practitioner
Community Hospital Oncology Physicians
Indianapolis, IN
Peer Reviewer
Medical Director
Humana
Fort Lauderdale, FL
- Expert Perspectives on the Assessment, Treatment, and Management of Atopic Dermatitis (AD)
- Rapid Updates on the Evolving Treatment Paradigm for Moderate to Severe AD
- Crossfire Debates on Telehealth and Communication Strategies for Collaborative AD Care
- Focused Discussions on Supporting Patient Adherence and Access to Needed Therapies
- Apply validated methods for atopic dermatitis (AD) diagnosis and disease severity assessment in adult and pediatric patients
- Evaluate current efficacy and safety evidence on new therapies for patients with moderate to severe AD
- Implement telehealth and other strategies to communicate with AD specialists to ensure that patients with moderate to severe disease receive needed therapies
- Incorporate methods to support patients with AD in accessing and adhering to needed therapies
No comments:
Post a Comment